Evaluation of the Role of Intravitreal Injection of TPA in Treatment of Refractory Diabetic Macular Edema.

Trial Profile

Evaluation of the Role of Intravitreal Injection of TPA in Treatment of Refractory Diabetic Macular Edema.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 01 Nov 2011

At a glance

  • Drugs Alteplase (Primary) ; Bevacizumab
  • Indications Diabetic macular oedema
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Nov 2011 Results published in Retina.
    • 14 Jun 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top